Home / Central Data Catalog / FRESH-PEF60063-EN
central

Cohort of HIV-Seropositive Individuals Infected by Use of Intravenous drugs: Prospective Study in Marseille, Avignon, Nice and Ile-de-France

France, 1995 - 2006
Reference ID
FRESH-PEF60063-en
Producer(s)
Maria Patrizia;CARRIERI, Yolande;OBADIA
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
39
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access
  • Contacts

    • Identification

    Survey ID number

    FRESH-PEF60063-en
    Title

    Cohort of HIV-Seropositive Individuals Infected by Use of Intravenous drugs: Prospective Study in Marseille, Avignon, Nice and Ile-de-France
    Abbreviation or Acronym

    MANIF-2000 FOLLOWED BY MANIF-2
    Country
    Name Country code
    France fr
    Kind of Data

    ['Clinical data','Biological data','Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Infectious disease medicine health theme
    Behavioral determinants: Addiction health determinant
    Behavioral determinants health determinant
    Keywords
    related diseases hepatic psychiatric genital and gynaecological secondary side-effects from treatment Health episodes cardiovascular neurological infectious prevention

    Coverage

    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"HIV-1 or HIV-2 seropositive patients that have been infected through intravenous drug use with an initial CD4 count greater than 300/mm3 and at clinical stage A or B.","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    Maria Patrizia;CARRIERI
    Yolande;OBADIA
    Producers
    Name Role
    OBSERVATOIRE REGIONAL DE LA SANTE (ORS PACA) sponsor
    Funding Agency/Sponsor
    Name
    AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE)
    DEPARTEMENT DES BOUCHES DU RHONE
    SIDACTION (ECS)

    Study authorization

    Agency
    Agency name
    CNIL

    Sampling

    Sample frame

    Unit Type

    ['Through organizations (health services or institutions, schools, businesses, etc.)']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    1995-01-01 2006-01-01
    Mode of data collection
    • {"concept":{"vocabURI":"SelfAdministeredQuestionnaire","vocab":"CESSDA"},"value":"Self-administered questionnaire"}
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity Health event/mortality Health care consumption and services

    Data Access

    Availability Status

    {"value":"Metadata-only access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_14cb"}]}

    Contacts

    Contacts
    Name Email
    Maria Patrizia;CARRIERI maria-patrizia.carrieri@inserm.fr
    Yolande;OBADIA yolande.obadia@inserm.fr
    Back to Catalog